Nugen technologies, INC.:1164879 [14-005721]
Ended Awarded
- Contract number
- HHSN26400001
- Awardee
-
Tecan Genomics, Inc. UEI R4DEKMG6K8N4
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,025
Award facts
- Contract value 100% obligated
- $10,025.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Tecan Genomics, Inc., a Switzerland-based manufacturer of life science laboratory automation and detection solutions, received a BPA Call contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD), a component of the National Institutes of Health, on September 17, 2014. This firm fixed-price contract, valued at $10,025.00, was to be completed by March 31, 2015, with performance conducted in Bethesda, MD. The award carried no set-aside designation and represents a call against Tecan Genomics' larger Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations, a single-award indefinite delivery vehicle valued at $100 million through March 31, 2025.
Under this BPA vehicle, Tecan Genomics provides biological materials and advanced genomic research technologies to support federal research programs across multiple NIH institutes and the Centers for Disease Control and Prevention. The company's contract portfolio demonstrates expertise in delivering specialized equipment and reagents, including RNA sequencing kits, methylation analysis systems, targeted genotyping services, and related products essential for infectious disease research, genomics studies, and aging-related scientific investigations. This particular call order exemplifies the company's consistent provision of firm fixed-price purchase orders supporting critical federal research initiatives.
Quick answers
Who was awarded contract HHSN26400001?
HHSN26400001 was awarded to Tecan Genomics, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on September 17, 2014.
How much is contract HHSN26400001 worth?
The government has obligated $10,025 on HHSN26400001.
Is contract HHSN26400001 an order under another contract?
Yes. HHSN26400001 is a BPA call under HHSN263201300006B, a blanket purchase agreement.
Was contract HHSN26400001 competed?
The extent of competition for HHSN26400001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award